Factors affecting treatment adherence to atomoxetine in ADHD: a systematic review

por Treuer T, Méndez L, Montgomery W, Wu S
Publicado 2016

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropath...

por Ogawa K, Fujikoshi S, Montgomery W, Alev L
Publicado 2015

Association between pain severity, depression severity, and use of health care services in Japan: results of a nationwide survey

por Vietri J, Otsubo T, Montgomery W, Tsuji T, Harada E
Publicado 2015

Sex differences in the course of schizophrenia across diverse regions of the world

por Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM
Publicado 2016

Detection, diagnosis, and treatment of Alzheimer’s disease dementia stratified by severity as reported by caregivers in Japan

por Montgomery W, Goren A, Kahle-Wrobleski K, Nakamura T, Ueda K
Publicado 2018

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients

por Novick D, Montgomery W, Aguado J, Peng XM, Haro JM
Publicado 2016

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine

por Imagawa H, Nagar SP, Montgomery W, Nakamura T, Sato M, Davis KL
Publicado 2018

Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine

por Montgomery W, Kadziola Z, Ye W, Xue HB, Liu L, Treuer T
Publicado 2015

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study

por Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM
Publicado 2015

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China

por Zhang L, Chen Y, Yue L, Liu Q, Montgomery W, Zhi L, Wang W
Publicado 2016

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China

por Wu J, He XN, Liu L, Ye W, Montgomery W, Xue HB, McCombs JS
Publicado 2015

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

por Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensl, MD, Ascher-Svanum H
Publicado 2014

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

por Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Dueñas H, Brugnoli R
Publicado 2016